Volgen
Agnieszka A. Kaczor
Agnieszka A. Kaczor
Geverifieerd e-mailadres voor umlub.pl - Homepage
Titel
Geciteerd door
Geciteerd door
Jaar
Current concepts and treatments of schizophrenia
P Stępnicki, M Kondej, AA Kaczor
Molecules 23 (8), 2087, 2018
6542018
Multi-target approach for drug discovery against schizophrenia
M Kondej, P Stępnicki, AA Kaczor
International journal of molecular sciences 19 (10), 3105, 2018
1102018
Oligomerization of G protein-coupled receptors: biochemical and biophysical methods
AA Kaczor, J Selent
Current medicinal chemistry 18 (30), 4606-4634, 2011
842011
Recent advances and applications of molecular docking to G protein-coupled receptors
D Bartuzi, AA Kaczor, KM Targowska-Duda, D Matosiuk
Molecules 22 (2), 340, 2017
802017
Chiral 1, 3, 4-oxadiazol-2-ones as highly selective FAAH inhibitors
JZ Patel, T Parkkari, T Laitinen, AA Kaczor, SM Saario, JR Savinainen, ...
Journal of medicinal chemistry 56 (21), 8484-8496, 2013
682013
Structure‐Based Virtual Screening for Dopamine D2 Receptor Ligands as Potential Antipsychotics
AA Kaczor, AG Silva, MI Loza, P Kolb, M Castro, A Poso
ChemMedChem 11 (7), 718-729, 2016
622016
Interplay between two allosteric sites and their influence on agonist binding in human μ opioid receptor
D Bartuzi, AA Kaczor, D Matosiuk
Journal of chemical information and modeling 56 (3), 563-570, 2016
542016
Non-peptide opioid receptor ligands-recent advances. Part I-agonists
A Kaczor, D Matosiuk
Current medicinal chemistry 9 (17), 1567-1589, 2002
512002
In vitro, molecular modeling and behavioral studies of 3-{[4-(5-methoxy-1H-indol-3-yl)-1, 2, 3, 6-tetrahydropyridin-1-yl] methyl}-1, 2-dihydroquinolin-2-one (D2AAK1) as a …
AA Kaczor, KM Targowska-Duda, B Budzyńska, G Biała, AG Silva, ...
Neurochemistry international 96, 84-99, 2016
462016
Optimization of 1, 2, 5‐thiadiazole carbamates as potent and selective ABHD6 inhibitors
JZ Patel, TJ Nevalainen, JR Savinainen, Y Adams, T Laitinen, RS Runyon, ...
ChemMedChem 10 (2), 253-265, 2015
402015
Overcoming Depression with 5-HT2A Receptor Ligands
A Zięba, P Stępnicki, D Matosiuk, AA Kaczor
International Journal of Molecular Sciences 23 (1), 10, 2021
382021
Computational methods for studying G protein-coupled receptors (GPCRs)
AA Kaczor, E Rutkowska, D Bartuzi, KM Targowska-Duda, D Matosiuk, ...
Methods in cell biology 132, 359-399, 2016
382016
Non-peptide opioid receptor ligands-recent advances. Part II-antagonists
A Kaczor, D Matosiuk
Current medicinal chemistry 9 (17), 1591-1603, 2002
382002
Protein–protein docking in drug design and discovery
AA Kaczor, D Bartuzi, TM Stępniewski, D Matosiuk, J Selent
Computational Drug Discovery and Design, 285-305, 2018
372018
The dopamine D2 receptor dimer and its interaction with homobivalent antagonists: homology modeling, docking and molecular dynamics
AA Kaczor, M Jörg, B Capuano
Journal of Molecular Modeling 22, 1-14, 2016
362016
Activation and allosteric modulation of human μ opioid receptor in molecular dynamics
D Bartuzi, AA Kaczor, D Matosiuk
Journal of Chemical Information and Modeling 55 (11), 2421-2434, 2015
362015
Modeling Complexes of Transmembrane Proteins: Systematic Analysis of Protein Protein Docking Tools
AA Kaczor, J Selent, F Sanz, M Pastor
Molecular informatics 32 (8), 717-733, 2013
362013
Oligomerization of G protein-coupled receptors: computational methods
J Selent, AA Kaczor
Current medicinal chemistry 18 (30), 4588-4605, 2011
362011
Thyroid peroxidase activity is inhibited by phenolic compounds—impact of interaction
E Habza-Kowalska, AA Kaczor, J Żuk, D Matosiuk, U Gawlik-Dziki
Molecules 24 (15), 2766, 2019
352019
Novel thiosemicarbazide derivatives with 4-nitrophenyl group as multi-target drugs: α-glucosidase inhibitors with antibacterial and antiproliferative activity
M Wos, M Miazga-Karska, AA Kaczor, K Klimek, Z Karczmarzyk, ...
Biomedicine & Pharmacotherapy 93, 1269-1276, 2017
352017
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20